2026

Rzasa, P. et al. (2026) BRAFⱽ⁶⁰⁰ᴱ-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism. Communications Biology, 6(1), 962. (doi: 10.1038/s42003-023-05331-x) (PMID:37735514) (PMCID:PMC10514332)

Farahmand, P. et al. (2026) Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for ⱽ⁶⁰⁰ᴱBRAF-driven premalignant tumour development in the mouse intestine. PLoS ONE, 21(3), e0337259. (doi: 10.1371/journal.pone.0337259) (PMID:41790744) (PMCID:PMC12965588)

2025

Rovers, S. et al. (2025) A minimally invasive transthoracic injection technique for reproducible intrapleural delivery in mice. Methods and Protocols, 8(3), 55. (doi: 10.3390/mps8030055) (PMID:40559443) (PMCID:PMC12195961)

2023

Chrisochoidou, Y. et al. (2023) Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease, 14(11), 725. (doi: 10.1038/s41419-023-06240-x) (PMID:37938546) (PMCID:PMC10632403)

Farahmand, P. et al. (2023) Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Frontiers in Toxicology, 5, 1200650. (doi: 10.3389/ftox.2023.1200650) (PMID:37441092) (PMCID:PMC10333928)

2021

Marini, A. et al. (2021) The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nature Communications, 12, 4920. (doi: 10.1038/s41467-021-25173-7) (PMID:34389715) (PMCID:PMC8363647)

Articles

Rzasa, P. et al. (2026) BRAFⱽ⁶⁰⁰ᴱ-mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism. Communications Biology, 6(1), 962. (doi: 10.1038/s42003-023-05331-x) (PMID:37735514) (PMCID:PMC10514332)

Farahmand, P. et al. (2026) Phosphorylations of serines 21/9 in glycogen synthase kinase 3α/β are dispensable for ⱽ⁶⁰⁰ᴱBRAF-driven premalignant tumour development in the mouse intestine. PLoS ONE, 21(3), e0337259. (doi: 10.1371/journal.pone.0337259) (PMID:41790744) (PMCID:PMC12965588)

Rovers, S. et al. (2025) A minimally invasive transthoracic injection technique for reproducible intrapleural delivery in mice. Methods and Protocols, 8(3), 55. (doi: 10.3390/mps8030055) (PMID:40559443) (PMCID:PMC12195961)

Chrisochoidou, Y. et al. (2023) Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells. Cell Death and Disease, 14(11), 725. (doi: 10.1038/s41419-023-06240-x) (PMID:37938546) (PMCID:PMC10632403)

Farahmand, P. et al. (2023) Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma. Frontiers in Toxicology, 5, 1200650. (doi: 10.3389/ftox.2023.1200650) (PMID:37441092) (PMCID:PMC10333928)

Marini, A. et al. (2021) The pathogenesis of mesothelioma is driven by a dysregulated translatome. Nature Communications, 12, 4920. (doi: 10.1038/s41467-021-25173-7) (PMID:34389715) (PMCID:PMC8363647)